Optimal Gestational Weight Gain for Women With Obesity

Abstract

ObjectiveTo determine the optimal gestational weight gain interval for women with obesity in order to minimize neonatal and maternal adverse events. MethodsSecondary analysis of the QUARISMA trial, including women with obesity who delivered a full-term singleton in cephalic presentation from 2008 to 2011 in Québec. The primary outcome was a composite risk of major neonatal morbidity. Secondary outcomes were composite risks of major maternal morbidity, minor neonatal and maternal morbidity, and cesarean delivery. Various ranges of weight gain were compared with the current recommendations (reference group) using logistic regression to identify an optimal gestational weight gain interval. In a secondary analysis, women with obesity were stratified by obesity class (I–III). ResultsAmong 16 808 eligible women with obesity, 3270 gained less weight than recommended, 4355 gained weight as recommended (5–9.09 kg), and 9183 gained more weight than recommended. Optimal gestational weight change for all women with obesity was –1 to +4 kg and was associated with reduced risk of major neonatal morbidity (aOR 0.49; 95%CI 0.33–0.73, P < 0.001) compared with the reference group. Analysis by class of obesity showed a reduced risk of major neonatal morbidity with a weight change of –1 to +4 kg for class I, –2 to +2 for class II), and –2 to +3 kg for class III. ConclusionCompared with the current guidelines, a gestational weight change of –1 to +4 kg is associated with reduced risk of adverse perinatal outcomes. While similar findings were seen among women with class I obesity, women with class II or III obesity could benefit from a lower weight gain.